Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)

Clinical trial NCT02960555 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT02960555

Sponsor

M.D. Anderson Cancer Center

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-02-08

Primary completion

2027-04-30

Enrollment

61

View on ClinicalTrials.gov